A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane
NCT03003078
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
Unresectable Locally Advanced Pancreatic Carcinoma
Interventions
DEVICE:
OncoSil™
Sponsor
OncoSil Medical Limited